Progressive Cone Dystrophy (PCD)
A group of rare inherited retinal diseases that primarily affect the cone photoreceptor cells of the retina.
Understanding Progressive Cone Dystrophy
Progressive Cone Dystrophy (PCD) is a group of rare inherited retinal diseases that primarily affect the cone photoreceptor cells of the retina.
Cone cells are responsible for:
- Detailed central vision
- Colour vision
- Vision in bright light
In Progressive Cone Dystrophy, cone cells gradually lose their ability to function and may eventually degenerate. This can lead to progressive changes in vision, including reduced visual acuity, difficulty distinguishing colours, and increased sensitivity to light.
The age of onset, severity, and rate of progression can vary significantly between individuals. Some people experience symptoms during childhood, while others may not notice vision changes until adulthood.
Progressive Cone Dystrophy can occur as an isolated retinal condition or as part of a broader group of inherited retinal diseases affecting both cones and rods.
Advances in genetic testing, retinal imaging, and gene-based research are improving understanding of Progressive Cone Dystrophy and creating opportunities for future treatments.
Retina International works with people affected by inherited retinal diseases, patient organisations, researchers, clinicians, and partners worldwide to advance research, improve access to information, and ensure that patient experiences help shape the future of retinal care.
What is Progressive Cone Dystrophy?
Progressive Cone Dystrophy is an inherited retinal condition characterised by the gradual loss of cone photoreceptor function.
The retina contains specialised cells called photoreceptors that capture light and send signals to the brain.
There are two main types of photoreceptors:
Rod cells
Rod cells support:
- Night vision
- Vision in low-light conditions
- Peripheral vision
Cone cells
Cone cells support:
- Colour vision
- Sharp central vision
- Vision in daylight
In Progressive Cone Dystrophy, cone cells become progressively damaged, affecting the ability to see fine details and perceive colours accurately.
Because cone cells are concentrated in the macula, the central area of the retina, vision tasks requiring precision are often affected first.
Progressive Cone Dystrophy is sometimes grouped with other cone disorders, including:
- Cone dystrophy
- Cone-rod dystrophy
- Achromatopsia (when cone function is absent from birth)
The distinction between these conditions depends on the pattern of retinal involvement, genetic cause, and progression over time.
9+ genes
Can be caused by changes in many genes, including ABCA4, CNGA3, CNGB3, GUCY2D and PDE6C.
3 inheritance patterns
May be inherited through autosomal recessive, autosomal dominant, or X-linked patterns.
Variable onset
Symptoms can begin in childhood or adulthood, with severity and progression varying between individuals.
How XLRS can affect vision
Reduced visual acuity
People may experience difficulty with:
- Reading
- Recognising faces
- Seeing fine details
- Viewing distant objects
Colour vision changes
Damage to cone cells can cause difficulty:
- Distinguishing colours
- Identifying colour differences
- Perceiving colour intensity
Light sensitivity (photophobia)
Many people with cone disorders experience discomfort in bright light.
This may lead to:
- Avoiding bright environments
- Wearing tinted lenses
- Difficulty adapting to changes in lighting
Reduced contrast sensitivity
Objects may become harder to distinguish from their surroundings.
.
Central vision loss
As cone function declines, detailed vision may become increasingly affected.
Reduced vision in daylight
Unlike many retinal conditions where low-light vision is affected first, cone disorders often cause greater difficulty in bright conditions.
Identifying Progressive Cone Dystrophy
Eye examination
An ophthalmologist evaluates:
- Visual function
- Retinal appearance
- Signs of degeneration
Visual acuity testing
Measures clarity of central vision.
Colour vision testing
Specialised tests assess the ability to identify and distinguish colours.
Optical coherence tomography (OCT)
OCT provides detailed images of retinal layers and helps identify:
- Loss of photoreceptor layers
- Changes in the macula
- Disease progression
Fundus photography
Retinal images help document structural changes over time.
Fundus autofluorescence (FAF)
FAF imaging can highlight changes in retinal pigment cells and areas of retinal stress.
Electroretinography (ERG)
ERG measures electrical activity from retinal cells.
Cone-specific ERG testing can identify reduced cone responses.
Genetic testing
Genetic testing can identify the mutation responsible and may help guide future treatment options.
A genetic diagnosis can:
- Confirm the condition
- Provide information about inheritance
- Support family members
- Enable participation in clinical research
Supporting vision and maintaining independence
Managing light sensitivity
Strategies may include:
- Tinted lenses
- Sunglasses
- Adaptive lighting
- Glare reduction
Low vision support
Support may include:
- Magnification devices
- Assistive technology
- Digital accessibility tools
- Vision rehabilitation
Educational support
Children and young people may benefit from:
- Accessible learning materials
- Classroom accommodations
- Specialist vision support
Workplace support
Adults may benefit from:
- Workplace adjustments
- Assistive technology
- Flexible working approaches
Emerging treatments
Research is exploring:
- Gene replacement therapy
- Gene editing approaches
- Retinal cell therapies
- Neuroprotective treatments
Supporting independence and quality of life
Living with Progressive Cone Dystrophy can involve adapting to gradual changes in vision.
People affected may experience challenges with:
- Education
- Employment
- Driving
- Reading
- Recognising faces
- Navigating unfamiliar environments
Support strategies may include:
- Early access to vision rehabilitation
- Assistive technologies
- Mobility training
- Peer support
- Patient organisations
Because Progressive Cone Dystrophy can affect people at different stages of life, personalised support is essential.
The experiences of people living with cone disorders are important in helping researchers understand which outcomes matter most and how future treatments should be evaluated.
Advancing the future of Progressive Cone Dystrophy treatment
Gene therapy
Researchers are exploring ways to replace or correct faulty genes responsible for cone dysfunction.
Potential approaches include:
- Delivering functional copies of genes
- Correcting disease-causing genetic changes
- Supporting cone survival
Retinal imaging and biomarkers
Advanced imaging helps researchers:
- Understand disease progression
- Identify treatment effects
- Improve clinical trial design
Natural history studies and registries
Long-term studies help establish:
- How vision changes over time
- Which measurements are most meaningful
- How treatments should be assessed
Clinical trials
Research is investigating new therapies for inherited cone disorders, including approaches targeting specific genetic causes.
Learn About Clinical TrialsInformation and community support
Take the Next Step
Progressive Cone Dystrophy highlights the importance of understanding the genetic causes of retinal degeneration and advancing research that protects and restores cone function.
Through collaboration between people affected by Progressive Cone Dystrophy, families, researchers, clinicians, and patient organisations worldwide, progress continues towards improved diagnosis, better support, and future treatments that may preserve vision.
